New cancer clinical trial: Fluorine F 18 Fluorthanatrace PET/CT in Treating Participants With Primary or Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Published on: July 27, 2018 at 12:00PM
Conditions:   Fallopian Tube Carcinoma;   Ovarian Carcinoma;   Primary Peritoneal Carcinoma;   Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma
Interventions:   Procedure: Computed Tomography;   Radiation: Fludeoxyglucose F-18;   Radiation: Fluorine F 18 Fluorthanatrace;   Procedure: Positron Emission Tomography
Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
Not yet recruiting
https://ift.tt/2Ahr3SH